Psychiatric adverse events during aripiprazole associated to other antipsychotics: a retrospective study of cases reported within the French PharmacoVigilance database

被引:0
|
作者
Kheloufi, F. [1 ]
Lepelley, M. [2 ]
Montastruc, F. [3 ]
Daveluy, A. [4 ]
Rouby, F. [1 ]
Drici, M. D. [5 ]
Mallaret, M. [2 ]
Micallef, J. [1 ]
机构
[1] Aix Marseille Univ, AP HM, Serv Pharmacol Clin & Pharmacovigilance,AMU,CNRS, Pharmacol Integree & Interface Clin & Ind,Inst Ne, Marseille, France
[2] CHU Grenoble, Ctr Reg Pharmacovigilance Grenoble, Pavillon E,CS 10217, Grenoble, France
[3] Univ Toulouse, Ctr Midipyrenees Pharmacovigilance Pharmacoepidem, Serv Pharmacol Med & Clin, Pharmacopole Midipyrenees,INSERM,U1027,CHU,Fac Me, Toulouse, France
[4] CHU Bordeaux, Ctr Reg Pharmacovigilance, Serv Pharmacol Med, INSERM,U1219, Bordeaux, France
[5] CHU Nice, Ctr Reg Pharmacovigilance Nice, Nice, France
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PS2 - 033
引用
收藏
页码:72 / 73
页数:2
相关论文
共 50 条
  • [41] Adverse drug events associated with metreleptin administration: a real-world pharmacovigilance study from 2014 to 2024 using the FAERS database
    He, Jinhao
    Luo, Xuehu
    Liu, Jie
    Sun, Mo
    Zhang, Chenning
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [42] Analysis of Reported Adverse Events Associated with Over-the-Scope Endoscopic Suturing System: an FDA MAUDE Database Study
    Wilson, Natalie
    Abdallah, Mohamed
    Jaber, Fouad
    Johnson Junior, Willie Mohammed
    McDonald, Nicholas
    Baliss, Michelle
    Singh, Shailendra
    Bilal, Mohammad
    OBESITY SURGERY, 2023, 33 (4) : 1253 - 1258
  • [43] Analysis of Reported Adverse Events Associated with Over-the-Scope Endoscopic Suturing System: an FDA MAUDE Database Study
    Natalie Wilson
    Mohamed Abdallah
    Fouad Jaber
    Willie Mohammed Johnson
    Nicholas McDonald
    Michelle Baliss
    Shailendra Singh
    Mohammad Bilal
    Obesity Surgery, 2023, 33 : 1253 - 1258
  • [44] Drugs related to Tourette-like syndrome: a case/non-case study in the French Pharmacovigilance Database and a comparison with cases reported in the Literature
    Lloret, S. Perez
    Rey, M. V.
    Rascol, O.
    Montastruc, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 112 - 112
  • [45] Immune checkpoint inhibitor rechallenge after immune-related adverse events in patients with cancer: Observational retrospective study using the WHO pharmacovigilance database
    Dolladille, C.
    Sassier, M.
    Fedrizzi, S.
    Chretien, B.
    Milliez, P.
    Lelong-Boulouard, V.
    Alexandre, J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 116 - 116
  • [46] Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: A case/non-case study in the French pharmacovigilance system database
    Moore, N
    KreftJais, C
    Haramburu, F
    Noblet, C
    Andrejak, M
    Ollagnier, M
    Begaud, B
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (05) : 513 - 518
  • [47] ANALYSIS OF REPORTED ADVERSE EVENTS ASSOCIATED WITH THE USE OF FUNCTIONAL LUMEN IMAGING PROBE DEVICES IN THE ESOPHAGUS AND STOMACH: AN FDA MAUDE DATABASE STUDY
    Jaber, Fouad
    Wilson, Natalie
    Johnson, Willie
    Alsakarneh, Saqr
    Mohamed, Mouhand
    Ahmed, Khalid
    Umar, Shifa
    Hanson, Brian
    Abdallah, Mohamed
    Bilal, Mohammad
    GASTROINTESTINAL ENDOSCOPY, 2023, 97 (06) : AB977 - AB978
  • [48] Adverse events during neoadjuvant chemotherapy for muscle invasive bladder cancer-a Swedish retrospective multicentre study of a clinical database
    Eriksson, Victoria
    Holmlund, Jennie
    Wiberg, Erik
    Johansson, Markus
    Huge, Ylva
    Alamdari, Farhood
    Svensson, Johan
    Aljabery, Firas
    Sherif, Amir
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2022, 11 (08) : 1105 - 1115
  • [49] Adverse Events During Pregnancy Associated With Entecavir and Adefovir: New Insights From a Real-World Analysis of Cases Reported to FDA Adverse Event Reporting System
    Yang, Renjun
    Yin, Nuoya
    Zhao, Ying
    Li, Dandan
    Zhang, Xuanling
    Li, Xingang
    Zhang, Yang
    Faiola, Francesco
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [50] Fluid retention-associated adverse events in patients treated with BCR::ABL1 inhibitors based on FDA Adverse Event Reporting System (FAERS): a retrospective pharmacovigilance study
    Huang, Jing
    Cai, Juanjuan
    Ye, Qingqing
    Jiang, Qiaoying
    Lin, Huan
    Wu, Lun
    BMJ OPEN, 2023, 13 (08):